Tectonic Therapeutic Stock Climbs as Broader Market Sinks
Tectonic Therapeutic shares jumped 3.6% to finish at $28.42 on Nasdaq Wednesday, a big move for the small biotech while the wider U.S. market slipped. MarketScreener data showed the stock was still down 5.2% for the last five sessions but up 36.2% since the start of the year. Biotech was a help. The SPDR S&P Biotech ETF climbed $2.08 to $129.83 and the iShares Nasdaq Biotechnology ETF added $3.25 to $167.50. Tectonic ended ahead of both main biotech benchmarks for the session.